Barry P Flannelly

CIK 1615842 · EVP & General Manager US · last filed 2026-06-16

Barry P Flannelly is an EVP & General Manager US who has filed 87 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for TARA, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$16.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions. 77 SEC filings were submitted jointly with INCYTE CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.04M

Companies

Total Filings

Lifetime Open-Market Net

-$16.16M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

906 CECIL RD
WILMINGTON, DE 19807

Related Filers

INCYTE CORP — 77 joint filings, latest 2025-10-27

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TARA	Director	—	$2.69	—	$0	7	2026-06-16
INCY	EVP & General Manager US	35,149	$114.97	$4.04M	-$16.16M	63	2025-07-17
GENOMIC HEALTH INC (GHDX) Delisted	Director	397	—	—	$0	3	2019-10-03

Recent Filings

87 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-06-16	TARA	Grant (A)	—	$0	EDGAR
2025-10-27	INCY	Notice (144)	−33,452	-$3.07M	EDGAR
2025-10-16	INCY	Notice (144)	−18,495	-$1.71M	EDGAR
2025-09-18	INCY	Notice (144)	−17,447	-$1.49M	EDGAR
2025-08-13	INCY	Notice (144)	−75,963	-$6.27M	EDGAR
2025-08-12	INCY	Notice (144)	−14,037	-$1.12M	EDGAR
2025-07-17	INCY	Sell (S)	−1,340	-$91.6K	EDGAR
2025-07-16	INCY	Notice (144)	−1,340	-$91.6K	EDGAR
2025-07-16	INCY	Mixed	−3,255	-$225.7K	EDGAR
2025-07-15	INCY	Notice (144)	−1,192	-$83.3K	EDGAR

Showing 1–10 of 87

Page 1 of 9 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.